Pharmaceutical Attorneys Dangerous Drugs Defective Medical Devices Medical Conditions Currently Accepted Cases Our Lawyers Do I Have a Case? Contact Us

You May Be At Risk For Suicide If...

While suicidal thoughts don't just occur in people who are taking prescription drugs, a large amount of people who were not at risk for suicide before may become at risk after taking certain dangerous drugs. Many drug manufacturers fail to adequately warn consumers about the possible risks these drugs pose to their health. The Food and Drug Administration is required to put a "black box" warning on any and all medications that may be serious threats to a person's health, however, the side effects are often downplayed and many people are still taking drugs that could cause them to have suicidal thoughts and tendencies.

Drugs such as Zoloft, Accutane, Prozac and Strattera are medications all used for a different purpose, but all have similar negative side effects in common. One of those serious side effects is increased risk of suicide. In fact, most antidepressants are forced to carry with them a black box label to warn those who take them that the drug may increase risk of suicide. Many Zoloft lawsuits have been brought forward in the last few years and it is causing the FDA to take notice. Drug companies should be help more responsible for their products, especially when the side effects can be as severe as suicide.

If you take an antidepressant or another drug and are concerned about the risk of suicide, contact your doctor to see what other options are available to you. If you have noticed yourself displaying suicidal tendencies and you are taking a prescription drug, or if a loved one has died because of their prescription drug, seek the help of a pharmaceutical injury attorney from Arnold & Itkin immediately. Our firm is experienced in dealing with big drug companies and will know how to fight for you to see that you get the compensation you deserve, so contact a dangerous drug lawyer today.

Categories: Dangerous Drugs

Comments

No Comments Posted
FDA Releases Order to Study Risks of Surgical Mesh
On Wednesday, January 4, the U.S. Food and Drug Administration (FDA) released an order to the makers of transvaginal mesh to step back and study the r... Read More [+]
Panel of Experts to Review Safety of Metal on Metal Hip Implants
The Food and Drug Administration (FDA) will hold a two day review panel in June to definitively rule on the safety of metal-on-metal (MoM) hip implant... Read More [+]
Off-Label Drug Use Leads to Infection And Blindness
Genentech's cancer-drug, Avastin , has been used for off-label treatment of macular degeneration since 2005, but more and more patients are coming... Read More [+]